Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
JACC. Cardiovascular Interventions|August 2, 2016
Prevalence and Clinical Impact of Tissue Protrusion After Stent Implantation: An ADAPT-DES Intravascular Ultrasound SubstudyFuyu Qiu, Gary S Mintz, Bernhard Witzenbichler, et al.
Journal of the American College of Cardiology|July 24, 2010
When is door-to-balloon time critical? Analysis from the HORIZONS-AMI (Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction) and CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) trialsBruce R Brodie, Bernard J Gersh, Thomas Stuckey, et al.
JACC. Cardiovascular Interventions|April 22, 2022
Dual Antiplatelet Therapy Discontinuation, Platelet Reactivity, and Adverse Outcomes After Successful Percutaneous Coronary InterventionBjörn Redfors, Ajay J Kirtane, Mengdan Liu, et al.
European Heart Journal|March 8, 2014
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudyAmar Narula, Roxana Mehran, Giora Weisz, et al.
Journal of Interventional Cardiology|March 19, 2010
Serial intravascular ultrasound analysis of the impact of myocardial bridge on neointimal proliferation after coronary stenting in patients with acute myocardial infarctionKenichi Tsujita, Akiko Maehara, Gary S Mintz, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Radial access in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty in acute myocardial infarction: the HORIZONS-AMI trialPhilippe Généreux, Roxana Mehran, Tullio Palmerini, et al.
Journal of the American College of Cardiology|June 4, 2011
Effect of switching antithrombin agents for primary angioplasty in acute myocardial infarction: the HORIZONS-SWITCH analysisGeorge D Dangas, Roxana Mehran, Eugenia Nikolsky, et al.
Lancet (London, England)|June 14, 2011
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trialGregg W Stone, Bernhard Witzenbichler, Giulio Guagliumi, et al.
International Journal of Cardiology|August 19, 2017
Does calcium burden impact culprit lesion morphology and clinical results? An ADAPT-DES IVUS substudyPeiren Shan, Gary S Mintz, Bernhard Witzenbichler, et al.
Circulation. Cardiovascular Interventions|January 2, 2015
Effect of obesity on coronary atherosclerosis and outcomes of percutaneous coronary intervention: grayscale and virtual histology intravascular ultrasound substudy of assessment of dual antiplatelet therapy with drug-eluting stentsSoo-Jin Kang, Gary S Mintz, Bernhard Witzenbichler, et al.
Pageof 12